- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07337408
Caracterización de las Prácticas de Destete en las UCI de Países del Sur Global
Caracterización de las Prácticas de Destete en las UCI de Países del Sur Global: Un Estudio Observacional Prospectivo
This is a prospective observational study to be conducted in intensive care units of Global South countries. Patients on mechanical ventilation for more than 12 hours who have initiated the weaning process and for whom the attending team plans extubation within the next 6 hours will be included. Data will be collected for each patient during the first 7 days after extubation, with follow-up until hospital discharge or death. We plan to conduct the study in intensive care units from Global South countries (low- and middle-income countries predominantly located in the Southern Hemisphere, though some in the Northern Hemisphere are also considered).
Descripción general del estudio
Estado
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Aline B Pereira
- Número de teléfono: +55 (47) 99181-8400
- Correo electrónico: linibp@hotmail.com
Ubicaciones de estudio
-
-
Santa Catarina
-
Joinville, Santa Catarina, Brasil
- Reclutamiento
- Centro Hospitalar Unimed Joinville
-
Contacto:
- Braz Pereira
- Número de teléfono: 55 47 99181-8400
- Correo electrónico: linibp@hotmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Patients receiving mechanical ventilation for more than 12 hours who are planning to undergo the first separation attempt from the invasive mechanical ventilation (as defined in the WIND Classification) in the next 6 hours or that has undergone a separation attempt less than 2 hours ago will be included.
Descripción
Inclusion Criteria:
- Age > 18 years.
- Receiving care at an intensive care unit.
- Endotracheal intubation.
- Mechanical ventilation for 12 hours or more.
- First separation attempt, as defined in the WIND Classification - "Separation attempt from mechanical ventilation: an spontaneous breathing trial with or without extubation, or an extubation directly performed without identified spontaneous breathing trial (whatever the type: planned or unplanned extubation)" - planned to occur in the next 6 hours or that occurred less than 2 hours ago.
Exclusion Criteria:
- Patients with prior extubation failure.
- Patients with prior spontaneous breathing trial failure.
- Patients unable to obey commands.
- Neuromuscular disease or cervical spinal cord injury.
- Tracheostomy.
- Do-not-resuscitate order or contraindication for reintubation.
- Lack of informed consent.
- Terminal extubation.
- Previously included in the study.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Extubation failure within 7 days.
Periodo de tiempo: 7 days.
|
Defined as reintubation or death within 7 days after extubation. |
7 days.
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Extubation within 28 days.
Periodo de tiempo: 28 days.
|
Defined as extubation within 28 days after first separation attempt. |
28 days.
|
|
Intensive care unit length of stay.
Periodo de tiempo: At intensive care unit discharge, up to 28 days.
|
Defined as the number of days from the time of first separation attempt until discharge from the intensive care unit. |
At intensive care unit discharge, up to 28 days.
|
|
Hospital length of stay.
Periodo de tiempo: At hospital discharge, up to 28 days.
|
Defined as the number of days from the time of first separation attempt until discharge from the hospital. |
At hospital discharge, up to 28 days.
|
|
Reintubation or death within 28 days.
Periodo de tiempo: 28 days.
|
Defined as composite criterion of reintubation or death within 28 days after first separation attempt. |
28 days.
|
|
Intensive care unit mortality.
Periodo de tiempo: At intensive care unit discharge, up to 28 days.
|
Defined as mortality from the time of first separation attempt until discharge from the intensive care unit. |
At intensive care unit discharge, up to 28 days.
|
|
Hospital mortality.
Periodo de tiempo: At hospital discharge, up to 28 days.
|
Defined as mortality from the time of first separation attempt until discharge from the hospital. |
At hospital discharge, up to 28 days.
|
|
Number of spontaneous breathing trials.
Periodo de tiempo: 28 days.
|
Defined as the number of spontaneous breathing trials performed after first separation attempt. |
28 days.
|
|
WIND classification.
Periodo de tiempo: 28 days.
|
Group 1 (short weaning): the first separation attempt resulted in a termination of the weaning process within 24 hours (successful separation or early death). • Group 2 (difficult weaning): weaning was terminated after more than 1 day but in less than 1 week after the first separation attempt (successful separation or death). • Group 3 (prolonged weaning): weaning was still not terminated 7 days after the first separation attempt (by success or death). |
28 days.
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- GS Wean - Observational
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .